Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Vincerx Pharma, Inc. (LSAC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "Vincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/11/2023 8-K Quarterly results
Docs: "Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
03/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/28/2023 8-K Quarterly results
03/28/2023 10-K Annual Report for the period ended December 31, 2022
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/14/2023 SC 13G Long Focus Capital Management, LLC reports a 6.7% stake in Vincerx Pharma, Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A GOLDMAN SACHS GROUP INC reports a 10.1% stake in VINCERX PHARMA, INC.
02/08/2023 SC 13G GOLDMAN SACHS GROUP INC reports a 9.8% stake in VINCERX PHARMA, INC.
01/03/2023 8-K Quarterly results
12/29/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/10/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
08/31/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/11/2022 8-K Quarterly results
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
06/07/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/12/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/12/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/29/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/29/2022 8-K Quarterly results
Docs: "Vincerx Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update"
03/29/2022 10-K Annual Report for the period ended December 31, 2021
02/14/2022 SC 13G/A TANG CAPITAL PARTNERS LP reports a 4.9% stake in Vincerx Pharma, Inc.
02/14/2022 SC 13G/A PUTNAM INVESTMENTS LLC reports a 0% stake in Vincerx Pharma Inc.
02/14/2022 SC 13G/A RTW INVESTMENTS, LP reports a 3.5% stake in Vincerx Pharma, Inc.
02/11/2022 SC 13G/A Affinity Asset Advisors, LLC reports a 5.4% stake in Vincerx Pharma, Inc.
02/10/2022 SC 13G Rubric Capital Management LP reports a 10% stake in Vincerx Pharma, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy